pipette
ESEspañol

Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression

David Feifel, Mathieu Seynaeve, Wiesław Jerzy Cubała, Fiona Dunbar, Gerhard Gründer, Rosa María Dueñas Herrero, Chandni Hindocha, Paul Liknaitzky, Sean Mcguigan, Sejal Mehta, Mimi Pierce, Dimitris Repantis, Claire Roberts, Frank Wiegand, Robert R. Conley

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Conclusions and Relevance In adults with treatment-resistant depression, single doses of intranasal mebufotenin benzoate were well tolerated and produced rapid, robust, and durable reductions in depressive symptoms.

Appeared: Wednesday, October 28. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.18380